# POTASSIUM CITRATE
> **ANDA214426** · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2021-02-19
## Drug
- **FDA Application Number:** ANDA214426
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CITRATE
- **Generic name:** Potassium Citrate
- **Active ingredients:** POTASSIUM CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HIBROW HLTHCARE
- **First approval:** 2021-02-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214426)
---
*MORVS · CC0 1.0*